
Anne Marie Falk
Examiner (ID: 427)
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 685 |
| Issued Applications | 242 |
| Pending Applications | 153 |
| Abandoned Applications | 292 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5125480
[patent_doc_number] => 20070237751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Human Cord Blood as a Source of Neural Tissue Repair of the Brain and Spinal Cord'
[patent_app_type] => utility
[patent_app_number] => 11/558411
[patent_app_country] => US
[patent_app_date] => 2006-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 26626
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20070237751.pdf
[firstpage_image] =>[orig_patent_app_number] => 11558411
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/558411 | Human cord blood as a source of neural tissue repair of the brain and spinal cord | Nov 8, 2006 | Issued |
Array
(
[id] => 5367029
[patent_doc_number] => 20090304588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'BIOLOGICALLY EXCITABLE CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/089460
[patent_app_country] => US
[patent_app_date] => 2006-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10371
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304588.pdf
[firstpage_image] =>[orig_patent_app_number] => 12089460
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/089460 | BIOLOGICALLY EXCITABLE CELLS | Oct 15, 2006 | Abandoned |
Array
(
[id] => 8896549
[patent_doc_number] => 08476070
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => 'Media for culturing stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/991077
[patent_app_country] => US
[patent_app_date] => 2006-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 43
[patent_no_of_words] => 25316
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11991077
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/991077 | Media for culturing stem cells | Aug 28, 2006 | Issued |
Array
(
[id] => 5601783
[patent_doc_number] => 20060292128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Methods of treating schizophrenia'
[patent_app_type] => utility
[patent_app_number] => 11/497914
[patent_app_country] => US
[patent_app_date] => 2006-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8791
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292128.pdf
[firstpage_image] =>[orig_patent_app_number] => 11497914
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/497914 | Methods of treating schizophrenia | Jul 31, 2006 | Abandoned |
Array
(
[id] => 5184698
[patent_doc_number] => 20070056052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Methods of generating knock-out rodents'
[patent_app_type] => utility
[patent_app_number] => 11/493280
[patent_app_country] => US
[patent_app_date] => 2006-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14111
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20070056052.pdf
[firstpage_image] =>[orig_patent_app_number] => 11493280
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/493280 | Methods of generating knock-out rodents | Jul 25, 2006 | Abandoned |
Array
(
[id] => 5154853
[patent_doc_number] => 20070037736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Therapeutic composition comprising the KAL protein and use of the KAL protein for the treatment of retinal, renal, neuronal and neural injury'
[patent_app_type] => utility
[patent_app_number] => 11/476880
[patent_app_country] => US
[patent_app_date] => 2006-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 15276
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20070037736.pdf
[firstpage_image] =>[orig_patent_app_number] => 11476880
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/476880 | Therapeutic composition comprising the KAL protein and use of the KAL protein for the treatment of retinal, renal, neuronal and neural injury | Jun 28, 2006 | Abandoned |
Array
(
[id] => 5699594
[patent_doc_number] => 20060216278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Entrapped stem cells and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/447405
[patent_app_country] => US
[patent_app_date] => 2006-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3912
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20060216278.pdf
[firstpage_image] =>[orig_patent_app_number] => 11447405
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/447405 | Entrapped stem cells and uses thereof | Jun 4, 2006 | Abandoned |
Array
(
[id] => 5753957
[patent_doc_number] => 20060223106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Early-stage multipotential stem cells in colonies of bone marrow stromal cells'
[patent_app_type] => utility
[patent_app_number] => 11/445541
[patent_app_country] => US
[patent_app_date] => 2006-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4604
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20060223106.pdf
[firstpage_image] =>[orig_patent_app_number] => 11445541
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/445541 | Early-stage multipotential stem cells in colonies of bone marrow stromal cells | Jun 1, 2006 | Abandoned |
Array
(
[id] => 5480812
[patent_doc_number] => 20090203769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Modulation of the integrin-linked kinase signaling pathway provides beneficial human cardiac hypertrophy and post myocardial infarction remodeling'
[patent_app_type] => utility
[patent_app_number] => 11/915680
[patent_app_country] => US
[patent_app_date] => 2006-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8587
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203769.pdf
[firstpage_image] =>[orig_patent_app_number] => 11915680
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/915680 | Modulation of the integrin-linked kinase signaling pathway provides beneficial human cardiac hypertrophy and post myocardial infarction remodeling | May 28, 2006 | Abandoned |
Array
(
[id] => 6536437
[patent_doc_number] => 20100015654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'Negative regulation of NK cell functions by EAT-2, a sap-related adaptor expressed in innate immune cells'
[patent_app_type] => utility
[patent_app_number] => 11/914512
[patent_app_country] => US
[patent_app_date] => 2006-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 27515
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015654.pdf
[firstpage_image] =>[orig_patent_app_number] => 11914512
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/914512 | Negative regulation of NK cell functions by EAT-2, a sap-related adaptor expressed in innate immune cells | May 14, 2006 | Abandoned |
Array
(
[id] => 5753482
[patent_doc_number] => 20060222631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex'
[patent_app_type] => utility
[patent_app_number] => 11/431436
[patent_app_country] => US
[patent_app_date] => 2006-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5319
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20060222631.pdf
[firstpage_image] =>[orig_patent_app_number] => 11431436
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/431436 | Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex | May 9, 2006 | Issued |
Array
(
[id] => 4778243
[patent_doc_number] => 20080286241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Transplantation of Differentiated Immature Adipocytes and Biodegradable Scaffold for Tissue Augmentation'
[patent_app_type] => utility
[patent_app_number] => 11/912108
[patent_app_country] => US
[patent_app_date] => 2006-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5207
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286241.pdf
[firstpage_image] =>[orig_patent_app_number] => 11912108
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/912108 | Transplantation of Differentiated Immature Adipocytes and Biodegradable Scaffold for Tissue Augmentation | Apr 20, 2006 | Abandoned |
Array
(
[id] => 5521480
[patent_doc_number] => 20090029461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'Immortalised Feeder Cells'
[patent_app_type] => utility
[patent_app_number] => 11/885106
[patent_app_country] => US
[patent_app_date] => 2006-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6236
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20090029461.pdf
[firstpage_image] =>[orig_patent_app_number] => 11885106
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/885106 | Immortalised Feeder Cells | Feb 22, 2006 | Abandoned |
Array
(
[id] => 5648391
[patent_doc_number] => 20060134123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Methods and means for targeted gene delivery'
[patent_app_type] => utility
[patent_app_number] => 11/348661
[patent_app_country] => US
[patent_app_date] => 2006-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11036
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134123.pdf
[firstpage_image] =>[orig_patent_app_number] => 11348661
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/348661 | Methods and means for targeted gene delivery | Feb 6, 2006 | Issued |
Array
(
[id] => 5648349
[patent_doc_number] => 20060134081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Use of marrow-derived glial progenitor cells as gene delivery vehicles into the central nervous system'
[patent_app_type] => utility
[patent_app_number] => 11/340322
[patent_app_country] => US
[patent_app_date] => 2006-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6080
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134081.pdf
[firstpage_image] =>[orig_patent_app_number] => 11340322
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/340322 | Use of marrow-derived glial progenitor cells as gene delivery vehicles into the central nervous system | Jan 24, 2006 | Abandoned |
Array
(
[id] => 4759406
[patent_doc_number] => 20080311632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Methods for Producing Methionine by Culturing a Microorganism Modified to Enhance Production of Cysteine'
[patent_app_type] => utility
[patent_app_number] => 12/159846
[patent_app_country] => US
[patent_app_date] => 2006-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8282
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311632.pdf
[firstpage_image] =>[orig_patent_app_number] => 12159846
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/159846 | Methods for producing methionine by culturing a microorganism modified to enhance production of cysteine | Jan 3, 2006 | Issued |
Array
(
[id] => 5699633
[patent_doc_number] => 20060216317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Delivery of polynucleotide agents to the central nervous system'
[patent_app_type] => utility
[patent_app_number] => 11/323644
[patent_app_country] => US
[patent_app_date] => 2005-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25565
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20060216317.pdf
[firstpage_image] =>[orig_patent_app_number] => 11323644
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/323644 | Delivery of polynucleotide agents to the central nervous system | Dec 28, 2005 | Abandoned |
Array
(
[id] => 5010482
[patent_doc_number] => 20070280961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'cDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses and process for the production of such viruses'
[patent_app_type] => utility
[patent_app_number] => 11/320487
[patent_app_country] => US
[patent_app_date] => 2005-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14620
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20070280961.pdf
[firstpage_image] =>[orig_patent_app_number] => 11320487
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/320487 | Infectious recombinant paramyxovirus from antigenomic cDNA | Dec 26, 2005 | Issued |
Array
(
[id] => 5747446
[patent_doc_number] => 20060110377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Immunologically privileged cells and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/296677
[patent_app_country] => US
[patent_app_date] => 2005-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18186
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20060110377.pdf
[firstpage_image] =>[orig_patent_app_number] => 11296677
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/296677 | Immunologically privileged cells and uses thereof | Dec 6, 2005 | Abandoned |
Array
(
[id] => 8081665
[patent_doc_number] => 08148148
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-03
[patent_title] => 'Neural progenitor cell populations'
[patent_app_type] => utility
[patent_app_number] => 11/281040
[patent_app_country] => US
[patent_app_date] => 2005-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16138
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/148/08148148.pdf
[firstpage_image] =>[orig_patent_app_number] => 11281040
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/281040 | Neural progenitor cell populations | Nov 15, 2005 | Issued |